MoneyWorks4Me

Aurobindo Pharma informs about analyst call

05 Aug 2019 Evaluate

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that an analyst / investor call on the Unaudited Financial Results of the Company for the first quarter ended 30th June 2019 is scheduled on 8th August 2019 at 8:30 AM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..